{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:24:33Z","timestamp":1790411073013,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejpn.2020.12.007","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T09:24:42Z","timestamp":1608715482000},"page":"58-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Hemimegalencephaly and tuberous sclerosis complex: A rare yet challenging association"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2813-3708","authenticated-orcid":false,"given":"Christina","family":"Sidira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymia","family":"Vargiami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinelopi","family":"Dragoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios I.","family":"Zafeiriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2020.12.007_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(05)78872-3","article-title":"Prevalence of tuberous sclerosis estimated by capture-recapture analysis","author":"O'Callaghan","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejpn.2020.12.007_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jmg.26.1.28","article-title":"Genetic aspects of tuberous sclerosis in the west of Scotland","volume":"26","author":"Sampson","year":"1989","journal-title":"J.\u00a0Med. Genet."},{"issue":"7","key":"10.1016\/j.ejpn.2020.12.007_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","year":"1993","journal-title":"Cell"},{"issue":"5327","key":"10.1016\/j.ejpn.2020.12.007_bib4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"Van Slegtenhorst","year":"1997","journal-title":"Science (80- )"},{"issue":"15","key":"10.1016\/j.ejpn.2020.12.007_bib5","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev."},{"issue":"18","key":"10.1016\/j.ejpn.2020.12.007_bib6","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.1128\/MCB.24.18.7965-7975.2004","article-title":"Biochemical and functional characterizations of small GTPase rheb and TSC2 GAP activity","volume":"24","author":"Li","year":"2004","journal-title":"Mol. Cell Biol."},{"issue":"21","key":"10.1016\/j.ejpn.2020.12.007_bib7","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling","volume":"99","author":"Tee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"15","key":"10.1016\/j.ejpn.2020.12.007_bib8","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","article-title":"Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward rheb","volume":"13","author":"Tee","year":"2003","journal-title":"Curr. Biol."},{"issue":"9","key":"10.1016\/j.ejpn.2020.12.007_bib9","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41436-020-0823-4","article-title":"TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study","volume":"22","author":"Og\u00f3rek","year":"2020","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.ejpn.2020.12.007_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr. Neurol."},{"issue":"5","key":"10.1016\/j.ejpn.2020.12.007_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/088307380201700512","article-title":"Hemimegalencephaly: Part 1. Genetic, clinical, and imaging aspects","volume":"17","author":"Flores-Sarnat","year":"2002","journal-title":"J.\u00a0Child Neurol."},{"issue":"11","key":"10.1016\/j.ejpn.2020.12.007_bib12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/08830738030180111101","article-title":"Part 2. Neuropathology suggests a disorder of cellular lineage","volume":"18","author":"Flores-Sarnat","year":"2003","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2020.12.007_bib13","first-page":"315","article-title":"On hypertrophy and atrophy of the brain","volume":"19","author":"Sims","year":"1835","journal-title":"Med Quir Trans"},{"key":"10.1016\/j.ejpn.2020.12.007_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/9780470994030.ch18","article-title":"Focal brain malformations: a spectrum of disorders along the mTOR cascade","volume":"288","author":"Crino","year":"2007","journal-title":"Novartis Found. Symp."},{"issue":"7","key":"10.1016\/j.ejpn.2020.12.007_bib15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1528-1167.2012.03506.x","article-title":"Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target","volume":"53","author":"Galanopoulou","year":"2012","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.ejpn.2020.12.007_bib16","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022392","article-title":"Malformations of cortical development and epilepsy","volume":"5","author":"Barkovich","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ejpn.2020.12.007_bib17","series-title":"Jasper's Basic Mechanisms of the Epilepsies [Internet]","first-page":"835","article-title":"mTOR and epileptogenesis in developmental brain malformations","author":"Wong","year":"2012"},{"issue":"SUPPL. 9","key":"10.1016\/j.ejpn.2020.12.007_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2009.02289.x","article-title":"Focal brain malformations: seizures, signaling, sequencing","volume":"50","author":"Crino","year":"2009","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.ejpn.2020.12.007_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00005072-196120040-00008","article-title":"Unilateral ganglioglioma in a tubero-sclerotic brain","volume":"20","author":"Davis","year":"1961","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejpn.2020.12.007_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0072-9752(07)87010-2","article-title":"Hemimegalencephaly syndrome","volume":"87","author":"Flores-Sarnat","year":"2007","journal-title":"Handb. Clin. Neurol."},{"issue":"12","key":"10.1016\/j.ejpn.2020.12.007_bib21","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1212\/01.wnl.0000183747.05269.2d","article-title":"A\u00a0developmental and genetic classification for malformations of cortical development","volume":"65","author":"Barkovich","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ejpn.2020.12.007_bib22","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/brain\/aws019","article-title":"A\u00a0developmental and genetic classification for malformations of cortical development: update 2012","volume":"135","author":"Barkovich","year":"2012","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ejpn.2020.12.007_bib23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.24793","article-title":"Malformations of cortical development","volume":"80","author":"Desikan","year":"2016","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.ejpn.2020.12.007_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrneurol.2016.81","article-title":"The mTOR signalling cascade: paving new roads to cure neurological disease","volume":"12","author":"Crino","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2020.12.007_bib25","first-page":"521","article-title":"New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and perspectives","volume":"235","author":"M\u00fchlebner","year":"2019","journal-title":"J.\u00a0Anat."},{"issue":"21","key":"10.1016\/j.ejpn.2020.12.007_bib26","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/WNL.0b013e3181e04325","article-title":"Biallelic TSC gene inactivation in tuberous sclerosis complex","volume":"74","author":"Crino","year":"2010","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ejpn.2020.12.007_bib27","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1750-3639.2010.00416.x","article-title":"Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events","volume":"20","author":"Qin","year":"2010","journal-title":"Brain Pathol."},{"issue":"6141","key":"10.1016\/j.ejpn.2020.12.007_bib28","doi-asserted-by":"crossref","first-page":"1237758","DOI":"10.1126\/science.1237758","article-title":"Somatic mutation, genomic variation, and neurological disease","volume":"341","author":"Poduri","year":"2013","journal-title":"Science (80- )"},{"issue":"6","key":"10.1016\/j.ejpn.2020.12.007_bib29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.24793","article-title":"Malformations of cortical development","volume":"80","author":"Desikan","year":"2016","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2020.12.007_bib30","first-page":"523","article-title":"Unilateral megalencephaly: correlation of MR imaging and pathologic characteristics","volume":"11","author":"Barkovich","year":"1990","journal-title":"Am. J. Neuroradiol."},{"issue":"6","key":"10.1016\/j.ejpn.2020.12.007_bib31","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/00004691-199611000-00002","article-title":"Pathogenesis and pathology of focal malformations of cortical development and epilepsy","volume":"13","author":"Kuzniecky","year":"1996","journal-title":"J.\u00a0Clin. Neurophysiol."},{"issue":"4","key":"10.1016\/j.ejpn.2020.12.007_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0887-8994(01)00318-6","article-title":"Radiologic-pathologic correlation in focal cortical dysplasia and hemimegalencephaly in 18 children","volume":"25","author":"Woo","year":"2001","journal-title":"Pediatr. Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2020.12.007_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-2008-1071490","article-title":"Hemimegalencephaly and neurofibromatosis","volume":"21","author":"Cusmai","year":"1990","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.1016\/j.ejpn.2020.12.007_bib34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0887-8994(97)00090-8","article-title":"Hypomelanosis of Ito associated with hemimegalencephaly: a clinicopathological study","volume":"17","author":"Tagawa","year":"1997","journal-title":"Pediatr. Neurol."},{"issue":"6","key":"10.1016\/j.ejpn.2020.12.007_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s002340000310","article-title":"Klippel-Trenaunay syndrome: frequency of cerebral and cerebellar hemihypertrophy on MRI","volume":"42","author":"Torregrosa","year":"2000","journal-title":"Neuroradiology"},{"issue":"4","key":"10.1016\/j.ejpn.2020.12.007_bib36","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0387-7604(12)80060-X","article-title":"Epidermal nevus syndrome with hemimegalencephaly: neuropathological study","volume":"13","author":"Sakuta","year":"1991","journal-title":"Brain Dev."},{"issue":"3","key":"10.1016\/j.ejpn.2020.12.007_bib37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1469-8749.1991.tb05116.x","article-title":"Hemimegalen-cephaly: diagnosis and teatment","volume":"33","author":"Trounce","year":"1991","journal-title":"Dev. Med. Child Neurol."},{"issue":"6","key":"10.1016\/j.ejpn.2020.12.007_bib38","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.10545","article-title":"Functional organization of the brain with malformations of cortical development","volume":"53","author":"Janszky","year":"2003","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.ejpn.2020.12.007_bib39","first-page":"831","article-title":"Spectrum of congenital CNS malformations in pediatric epilepsy","volume":"41","author":"Sanghvi","year":"2004","journal-title":"Indian Pediatr."},{"issue":"4","key":"10.1016\/j.ejpn.2020.12.007_bib40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/08830738050200041201","article-title":"Clinical aspects of hemimegalencephaly by means of a nationwide survey","volume":"20","author":"Sasaki","year":"2005","journal-title":"J.\u00a0Child Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2020.12.007_bib41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1148\/radiographics.8.3.3380994","article-title":"Pediatric case of the day","volume":"8","author":"Towbin","year":"1988","journal-title":"Hemimegalencephaly. Radiographics"},{"issue":"2","key":"10.1016\/j.ejpn.2020.12.007_bib42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2990.1988.tb00875.x","article-title":"A\u00a0clinicopathological study of four cases","volume":"14","author":"Robain","year":"1988","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"4","key":"10.1016\/j.ejpn.2020.12.007_bib43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/088307389400900424","article-title":"Unilateral megalencephaly and tuberous sclerosis: related disorders?","volume":"9","author":"Maloof","year":"1994","journal-title":"J.\u00a0Child Neurol."},{"issue":"10","key":"10.1016\/j.ejpn.2020.12.007_bib44","first-page":"1935","article-title":"Hemimegalencephaly and focal megalencephaly in tuberous sclerosis complex","volume":"19","author":"Griffiths","year":"1998","journal-title":"Am. J. Neuroradiol."},{"issue":"9","key":"10.1016\/j.ejpn.2020.12.007_bib45","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/088307380201700905","article-title":"Hemimegalencephaly in tuberous sclerosis complex","volume":"17","author":"Galluzzi","year":"2002","journal-title":"J.\u00a0Child Neurol."},{"issue":"5","key":"10.1016\/j.ejpn.2020.12.007_bib46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-2002-36740","article-title":"Epilepsy surgery outcome in children with focal epilepsy due to tuberous sclerosis complex","volume":"33","author":"Karenfort","year":"2002","journal-title":"Neuropediatrics"},{"issue":"4","key":"10.1016\/j.ejpn.2020.12.007_bib47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1440-1673.2003.01216.x","article-title":"Hemimegalencephaly with tuberous sclerosis: a longitudinal imaging study","volume":"47","author":"Parmar","year":"2003","journal-title":"Australas. Radiol."},{"issue":"5","key":"10.1016\/j.ejpn.2020.12.007_bib48","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/088307380401900516","article-title":"Bilateral decreased oxygenation during focal status epilepticus in a neonate with hemimegalencephaly","volume":"19","author":"Alfonso","year":"2004","journal-title":"J.\u00a0Child Neurol."},{"issue":"6","key":"10.1016\/j.ejpn.2020.12.007_bib49","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.braindev.2004.11.004","article-title":"Longitudinal MR findings in a patient with hemimegalencephaly associated with tuberous sclerosis","volume":"27","author":"Sakuma","year":"2005","journal-title":"Brain Dev."},{"issue":"9","key":"10.1016\/j.ejpn.2020.12.007_bib50","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1212\/01.WNL.0000154465.87255.78","article-title":"Hemimegalencephaly and tuberous sclerosis complex","volume":"64","author":"Cartwright","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ejpn.2020.12.007_bib51","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ajmg.a.31024","article-title":"Epidemiology of hemimegalencephaly: a case series and review","volume":"139A","author":"Tinkle","year":"2005","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.ejpn.2020.12.007_bib52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/0883073807299960","article-title":"Intractable epilepsy in hemimegalencephaly and tuberous sclerosis complex","volume":"22","author":"Guerra","year":"2007","journal-title":"J.\u00a0Child Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2020.12.007_bib53","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00381-007-0463-x","article-title":"Longitudinal CT and MR appearances of hemimegalencephaly in a patient with tuberous sclerosis","volume":"24","author":"Balaji","year":"2008","journal-title":"Child\u2019s Nerv. Syst."},{"issue":"5","key":"10.1016\/j.ejpn.2020.12.007_bib54","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.pediatrneurol.2015.06.020","article-title":"Hemispherectomy for hemimegalencephaly due to tuberous sclerosis and a review of the literature","volume":"53","author":"Cuddapah","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ejpn.2020.12.007_bib55","author":"Hahn"},{"key":"10.1016\/j.ejpn.2020.12.007_bib56","article-title":"Prenatal diagnosis of hemimegalencephaly revealing tuberous sclerosis complex","author":"Bruet","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ejpn.2020.12.007_bib57","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","article-title":"TuberOus SClerosis registry to increase disease Awareness (TOSCA) \u2013 baseline data on 2093 patients","volume":"12","author":"Kingswood","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"10.1016\/j.ejpn.2020.12.007_bib58","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2009","journal-title":"Epilepsia"},{"issue":"14","key":"10.1016\/j.ejpn.2020.12.007_bib59","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1177\/0883073817737446","article-title":"Predictors of drug-resistant epilepsy in tuberous sclerosis complex","volume":"32","author":"Jeong","year":"2017","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2020.12.007_bib60","series-title":"Dysplasias of Cerebral Cortex and Epilepsy","first-page":"285","article-title":"Hemimegalencephaly: clinical and EEG characteristics","author":"Vigevano","year":"1996"},{"issue":"9","key":"10.1016\/j.ejpn.2020.12.007_bib61","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00381-014-2392-9","article-title":"Hemimegalencephaly without epilepsy: case report","volume":"30","author":"James","year":"2014","journal-title":"Child\u2019s Nerv. Syst."},{"issue":"8","key":"10.1016\/j.ejpn.2020.12.007_bib62","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp.55.8.720","article-title":"Hemimegalencephaly and normal intellectual development","volume":"55","author":"Fusco","year":"1992","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.ejpn.2020.12.007_bib63","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1684\/epd.2019.1041","article-title":"Late adult-onset epilepsy in a patient with hemimegalencephaly","volume":"21","author":"Climans","year":"2019","journal-title":"Epileptic Disord."},{"issue":"MAR","key":"10.1016\/j.ejpn.2020.12.007_bib64","first-page":"1","article-title":"Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation","volume":"7","author":"LaSarge","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.ejpn.2020.12.007_bib65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/fnl-2018-0001","article-title":"The mTOR pathway in treatment of epilepsy: a clinical update","volume":"13","author":"Griffith","year":"2018","journal-title":"Future Neurol."},{"issue":"8","key":"10.1016\/j.ejpn.2020.12.007_bib66","first-page":"1479","article-title":"Hemimegalencephaly: a longitudinal MR study","volume":"15","author":"Wolpert","year":"1994","journal-title":"Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.ejpn.2020.12.007_bib67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3171\/2014.10.PEDS14155","article-title":"Hemispherectomy for treatment of refractory epilepsy in the pediatric age group: a systematic review","volume":"15","author":"Griessenauer","year":"2015","journal-title":"J.\u00a0Neurosurg. Pediatr."},{"issue":"8","key":"10.1016\/j.ejpn.2020.12.007_bib68","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s00381-006-0149-9","article-title":"Hemimegalencephaly: clinical implications and surgical treatment","volume":"22","author":"Di Rocco","year":"2006","journal-title":"Child\u2019s Nerv. Syst."},{"issue":"6","key":"10.1016\/j.ejpn.2020.12.007_bib69","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3171\/2014.8.PEDS13613","article-title":"Unilateral holohemispheric central nervous system lesions associated with medically refractory epilepsy in the pediatric population: a retrospective series of hemimegalencephaly and Rasmussen's encephalitis","volume":"14","author":"Wang","year":"2014","journal-title":"J.\u00a0Neurosurg. Pediatr."},{"issue":"4","key":"10.1016\/j.ejpn.2020.12.007_bib70","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/0883073814539558","article-title":"Early modified functional hemispherectomy in a young infant with ohtahara syndrome and hemimegalencephaly","volume":"30","author":"Nachanakian","year":"2015","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2020.12.007_bib71","series-title":"Textbook of Pediatric Neurosurgery","first-page":"1","author":"Massimi","year":"2018"},{"issue":"2","key":"10.1016\/j.ejpn.2020.12.007_bib72","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/brain\/awh681","article-title":"Contralateral hemimicrencephaly and clinical\u2013pathological correlations in children with hemimegalencephaly","volume":"129","author":"Salamon","year":"2006","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.ejpn.2020.12.007_bib73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0387-7604(94)90060-4","article-title":"Surgical vs. medical treatment of seizures in hemimegalencephaly","volume":"16","author":"Bonioli","year":"1994","journal-title":"Brain Dev."},{"issue":"2","key":"10.1016\/j.ejpn.2020.12.007_bib74","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/epi.12010","article-title":"Posthemispherectomy hydrocephalus: results of a comprehensive, multiinstitutional review","volume":"54","author":"Lew","year":"2013","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.ejpn.2020.12.007_bib75","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/brain\/awg052","article-title":"Clinical outcomes of hemispherectomy for epilepsy in childhood and adolescence","volume":"126","author":"Devlin","year":"2003","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ejpn.2020.12.007_bib76","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/WNL.0b013e31827dead9","article-title":"Longitudinal seizure outcome and prognostic predictors after hemispherectomy in 170 children","volume":"80","author":"Moosa","year":"2013","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/j.ejpn.2020.12.007_bib77","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"For subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ejpn.2020.12.007_bib78","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ana.24523","article-title":"Everolimus for subependymal giant cell astrocytoma: 5-year final analysis","volume":"78","author":"Franz","year":"2015","journal-title":"Ann. Neurol."},{"issue":"9861","key":"10.1016\/j.ejpn.2020.12.007_bib79","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ejpn.2020.12.007_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0158476","article-title":"Long-term use of everolimus in patients with tuberous sclerosis complex: final results from the EXIST-1 study","volume":"11","author":"Franz","year":"2016","journal-title":"PloS One"},{"issue":"9869","key":"10.1016\/j.ejpn.2020.12.007_bib81","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ejpn.2020.12.007_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180939","article-title":"Everolimus long-term use in patients with tuberous sclerosis complex: four-year update of the EXIST-2 study","volume":"12","author":"Bissler","year":"2017","journal-title":"PloS One"},{"issue":"10056","key":"10.1016\/j.ejpn.2020.12.007_bib83","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ejpn.2020.12.007_bib84","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S2352-4642(18)30099-3","article-title":"Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial","volume":"2","author":"Curatolo","year":"2018","journal-title":"Lancet Child Adolesc Heal"},{"issue":"5","key":"10.1016\/j.ejpn.2020.12.007_bib85","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1212\/CPJ.0000000000000514","article-title":"Everolimus for treatment-refractory seizures in TSC","volume":"8","author":"Franz","year":"2018","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"10.1016\/j.ejpn.2020.12.007_bib86","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/0883073818813238","article-title":"mTOR inhibitors as a new therapeutic strategy in treatment resistant epilepsy in hemimegalencephaly: a case report","volume":"34","author":"Xu","year":"2019","journal-title":"J.\u00a0Child Neurol."},{"issue":"182","key":"10.1016\/j.ejpn.2020.12.007_bib87","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005271","article-title":"Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder","volume":"5","author":"Parker","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.ejpn.2020.12.007_bib88","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/acn3.494","article-title":"Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders","volume":"4","author":"Krueger","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"10.1016\/j.ejpn.2020.12.007_bib89","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1212\/WNL.0000000000007749","article-title":"A\u00a0randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex","volume":"93","author":"Overwater","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ejpn.2020.12.007_bib90","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/cap.2016.0100","article-title":"Beneficial effects of everolimus on autism and attention-deficit\/hyperactivity disorder symptoms in a group of patients with tuberous sclerosis complex","volume":"27","author":"Kilincaslan","year":"2017","journal-title":"J.\u00a0Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.ejpn.2020.12.007_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/2070619","article-title":"Improvement in impaired social cognition but not seizures by everolimus in a child with tuberous sclerosis-associated autism through increased serum antioxidant proteins and oxidant\/antioxidant status","volume":"2019","author":"Yui","year":"2019","journal-title":"Case Rep Pediatr"},{"issue":"1","key":"10.1016\/j.ejpn.2020.12.007_bib92","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13041-016-0222-6","article-title":"Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation","volume":"9","author":"Hwang","year":"2016","journal-title":"Mol. Brain"},{"issue":"1","key":"10.1016\/j.ejpn.2020.12.007_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.braindev.2018.07.003","article-title":"Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan","volume":"41","author":"Mizuguchi","year":"2019","journal-title":"Brain Dev."},{"issue":"6","key":"10.1016\/j.ejpn.2020.12.007_bib94","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.braindev.2014.08.010","article-title":"Infantile tauopathies: hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma","volume":"37","author":"Sarnat","year":"2015","journal-title":"Brain Dev."},{"issue":"2","key":"10.1016\/j.ejpn.2020.12.007_bib95","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pneurobio.2008.03.002","article-title":"Microtubule-associated protein tau in development, degeneration and protection of neurons","volume":"85","author":"Wang","year":"2008","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10.1016\/j.ejpn.2020.12.007_bib96","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/brain\/aws013","article-title":"Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies","volume":"135","author":"Irwin","year":"2012","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ejpn.2020.12.007_bib97","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12031-011-9551-1","article-title":"Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43","volume":"45","author":"Mackenzie","year":"2011","journal-title":"J.\u00a0Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.ejpn.2020.12.007_bib98","doi-asserted-by":"crossref","first-page":"330","DOI":"10.5114\/fn.2012.32363","article-title":"Hemimegalencephaly: foetal tauopathy with mTOR hyperactivation and neuronal lipidosis","volume":"4","author":"Sarnat","year":"2012","journal-title":"Folia Neuropathol."},{"issue":"6","key":"10.1016\/j.ejpn.2020.12.007_bib99","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.mehy.2011.03.003","article-title":"Is intractable epilepsy a tauopathy?","volume":"76","author":"Xi","year":"2011","journal-title":"Med. Hypotheses"},{"issue":"6","key":"10.1016\/j.ejpn.2020.12.007_bib100","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ejpn.2018.08.005","article-title":"Diagnosis of tuberous sclerosis complex in the fetus","volume":"22","author":"Dragoumi","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"6","key":"10.1016\/j.ejpn.2020.12.007_bib101","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ejpn.2018.06.007","article-title":"Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): multicentre clinical experience","volume":"22","author":"Krueger","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2020.12.007_bib102","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-019-1077-6","article-title":"Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study","volume":"14","author":"Saffari","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.ejpn.2020.12.007_bib103","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1111\/epi.14529","article-title":"Everolimus in infants with tuberous sclerosis complex\u2013related West syndrome: first results from a single-center prospective observational study","volume":"59","author":"Samueli","year":"2018","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ejpn.2020.12.007_bib104","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejpn.2017.07.018","article-title":"Dramatic relapse of seizures after everolimus withdrawal","volume":"22","author":"Mingarelli","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379820302312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379820302312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:37:25Z","timestamp":1761071845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379820302312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":104,"alternative-id":["S1090379820302312"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2020.12.007","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemimegalencephaly and tuberous sclerosis complex: A rare yet challenging association","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2020.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}